<DOC>
	<DOCNO>NCT01238783</DOCNO>
	<brief_summary>To assess safety efficacy AL-15469A 0.5 % /AL-6515 0.3 % Ophthalmic Suspension treatment bacterial conjunctivitis</brief_summary>
	<brief_title>Safety Efficacy AL-15469A 0.5 % / AL-6515 0.3 % Ophthalmic Suspension Treatment Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<criteria>Male female patient race 5 year age old time Day 1 visit primary clinical diagnosis bacterial conjunctivitis . Onset bacterial conjunctivitis ( sign symptom ) 4 day Presence punctal plug punctal occlusion Visual Acuity worse 20/80 Upper respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>